{
    "paper_id": "3e73c792aebcdd62d97108b0ca3e4a4b84c9d01d",
    "metadata": {
        "title": "SUPPLEMENTARY FILE -INTERVIEW GUIDES: HEALTHCARE PROFESSIONALS AND PEOPLE AFFECTED BY CANCER",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "\u2022 Have you been on a prescribing course and if so which one?",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 How do you keep up to date with prescribing given how new immunotherapy is as a pathway?",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Section 2: Understandings of immunotherapy \u2022 To start, please could you tell me in your own words what your understanding of cancer immunotherapy treatment is and how it works?",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 What does your role in supporting cancer immunotherapy entail?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 3: Supporting immunotherapy care"
        },
        {
            "text": "\u2022 Please could you tell me a bit about your experience of caring for/ supporting people being treated with cancer immunotherapy with immune checkpoint inhibitors?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 3: Supporting immunotherapy care"
        },
        {
            "text": "\u2022 What do you think are patients' priorities and expectations of treatment?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 How do patients respond to support?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 How is information about immunotherapy treatment communicated to patients?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 Do you have training on how to help patients make decisions? Do you have training on how to explore patients' unmet needs?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 What psychological support is offered to patients? \u2022 How is treatment/support delivered out of hours?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 How do you support patients' self-management?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 Do professionals experience uncertainty in prescribing/delivering treatment and support for immunotherapy?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 4: Information giving, support and patient expectations"
        },
        {
            "text": "\u2022 What would you say has particularly prepared you for prescribing or supporting immunotherapy treatment/care?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 What knowledge and skills do healthcare professionals (doctors/nurses/pharmacists) need to provide safe and effective high-quality care and support for people being treated with cancer immunotherapy?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 What aspects of cancer immunotherapy would you like to know more about and why?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 How might your ongoing immunotherapy education and training needs be best addressed?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 What are the challenges for you of accessing education and training?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 Why is it important that healthcare professionals working in other care settings, for example, emergency admissions, general practice, primary care and acute hospital settings know about and understand cancer immunotherapy treatment regimes?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 What education is available to patients?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 How is knowledge disseminated across multi-professional teams?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 What are your thoughts on certification for immunotherapy?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 6: Knowledge, skills and education"
        },
        {
            "text": "\u2022 Overall, how would you describe your experience providing immunotherapy treatment to date?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 7: Final thoughts"
        },
        {
            "text": "\u2022 What has been the influence of COVID-19?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 7: Final thoughts"
        },
        {
            "text": "\u2022 Is there anything else you would like to add? BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open doi: 10.1136/bmjopen-2020-043750 :e043750.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Section 7: Final thoughts"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Did you have any concerns about immunotherapy? If so, what were they and how were these dealt with? Section 6: Immunotherapy treatment experience 13. Can you tell me about your immunotherapy treatment experience? 14. What has your experience been like between each treatment cycle? 15. Have you experienced any side effects? If so",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Section 5: Delivery of effective care/support\u2022 How do you define effective care/ support?",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}